the aid library

LIST OPTIONS

Filter

535

Download (160)

View PDF (185)

Good practice statement on the use of second booster doses for COVID 19 vaccines

World Health Organization WHO (2022) C_WHO

18 August 2022

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Download (171)

View PDF (221)

J12. Wellbeing: identification and prevention of burnout, depression and suicide among child mental health clinicians

Frances Javier, Julie Chilton & Andrés Martin IACAPAP (2015) C1

Download (186)

View PDF (245)

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir... more

External Link

Burnout Syndrome amongst Medical Students in Cameroon: A Cross-Sectional Analysis of the Determinants in Preclinical and Clinical Students

Njim T., H. Makebe, L. Toukam, et. al. Hindawi Psychiatry Journal (2019) C1

Volume 2019, Article ID 4157574, 7 pages https://doi.org/10.1155/2019/4157574

Download (289)

View PDF (178)

Praxisleitfaden: Prävention und Umgang mit Gewalt- und Gefährdungssituationen/Risikomanagement

Unicef (2019) C_UNICEF

Der vorliegende Leitfaden ist als praktisches Tool gedacht, das Leitungs-, Fach- und Betreuungskräfte dabei unterstützen soll, Mindeststandard 4 (Prävention und Umgang mit Gewalt- und Gefährdungssituationen/Risikomanagement) umzusetzen und in ihren Arbeitsalltag zu integrieren. Der Leitfaden ver... more

Download (179)

View PDF (231)

EMCDDA Monographs

T. Rhodes; D. Hedrich European Monitoring Centre for Drugs and Drug Addiction (2010) C2

Harm reduction: evidence, impacts and challenges -10-

Download (174)

View PDF (224)

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis (CDC)

Centers for Diseases Control and Prevention (2019) C_CDC

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Accessed: 08.10.2019

Download (368)

View PDF (388)

Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer

World Health Organization WHO (2020) C_WHO

This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the... more

Download (208)

View PDF (416)

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

Centers for Disease Control and Prevention, National Center for HIVAIDS, et. al (2013) C_CDC

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination.

Download (175)

View PDF (161)

Información Básica para Tomadores de Muestras de test de VPH

Ministerio de Salud Argentina (2021) C2

Esta carpeta ofrece información básica acerca de la estrategia de tamizaje basada en el test de VPH. Tiene como principales destinatariosa los integrantes del equipo de salud que realizan las tomas de las muestras para el tamizaje en las provincias que incorporaron esta nueva tecnología [ginecól... more

Download (639)

View PDF (716)

India: National Guidelines for HIV Testing

National AIDS Control Organisation (NACO), Ministry of Health & Family Welfare, Government of India (2015) C1

Download (327)

View PDF (200)

Standard treatment guidelines medicine (Respiratory Diseases) India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

External Link

HIV 2016/2017

C. Hoffmann und J. K. Rockstroh Medizin Fokus Verlag (2016) C2

External Link

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al. A. Benzacar; HIV i-BASETREATMENT ACTION GROUP (2015)

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development

Download (430)

View PDF (423)

Geographical distribution of areas with a high prevalence of HTLV-1 infection

European Centre for Disease Prevention and Control (ECDC) (2015) C1

ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i... more